YungJin Pharmaceutical company received U.S. FDA acknowledge in the efficacy of COPD treatment on Phase 1 clinical trial

On Feb 21, YungJin Pharmaceutical company announced that they received U.S. FDA acknowledge in the efficacy of COPD (chronic obstructive pulmonary disease) treatment on Phase 1 clinical trial in the global natural drug development project.

YungJin's global natural medicine drug project (YPL-001: COPD treatment) was selected as 'Industrial original technology development project for creating ea...